You are seeing these quotes based on previous browsing related to sectors such as
| Latest | Forecast | |
|---|---|---|
| Div Yield | 0.0% | 0.0% |
| Div Cover | n/a | n/a |
| Op Mrgn | 0.0% | n/a |
| ROCE | 0.0% |
| Latest | Forecast | |
|---|---|---|
| P/E | -6.5 | 0.0 |
| PEG | 0.0 | -999,999.0 |
| Price / Revenue | 0.0 | 0.0 |
| Price / Book value | 4.0 |
| Latest | Forecast | |
|---|---|---|
| Revenue | n/a | 0.0% |
| PBT | 0.0% | n/a |
| EPS | 0.0% | 0.0% |
| DPS | n/a | 0.0% |
| Year Ending | Revenue (£m) |
Pre-tax (£m) |
EPS | P/E | PEG | EPS Growth | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 2017-12-31 | n/a | -3.55 | -237.50p | -2.3 | 0.0 | n/a | n/a | 0.0% |
| 2018-12-31 | n/a | -4.83 | -117.50p | -0.9 | 0.0 | n/a | n/a | 0.0% |
| 2019-12-31 | n/a | -2.72 | -4,135.00p | 0.0 | 0.0 | n/a | n/a | 0.0% |
| 2020-12-31 | n/a | -1.54 | -3.81p | -5.1 | 0.0 | n/a | n/a | 0.0% |
| 2021-12-31 | n/a | -1.68 | -2.34p | -15.5 | 0.0 | n/a | n/a | 0.0% |
| ValiRx expecting to grant extension of exclusivity to TheoremRx Sharecast News | 17 Jun |
|---|---|
| ValiRx amends longstanding licence deal with Cancer Research Technology Sharecast News | 20 Dec |
| Holding(s) in Company | 30-Sep-22 08:49 |
|---|---|
| Live Shareholder Q&A and industry events | 22-Sep-22 07:00 |
| Appointment of Interim Chief Scientific Officer | 08-Sep-22 07:01 |
| Proposed Appointment of Non-Executive Director | 06-Sep-22 07:16 |
| Issue of Share Options | 06-Sep-22 07:00 |